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ABSTRACT
Lichens are symbiotic relationship between fungi and algae or cyanobacteria. Secondary metabolites from lichens are known as lichen substances. We 
investigated depsidone and depside from lichens 1-6 in the context of their action to prevent gastric ulcer on the model of HCl/ethanol in mice for the first time. 
Doses of 30 mg/kg of lichen substances 1-6 and positive control (lansoprazole) significantly diminished the lesion index compared with negative control (treated 
only with HCl/EtOH). Lobaric acid 1, atranorin 2 and psoromic acid 5 reduced the gastric lesions by 76%, 63% and 65%, while for variolaric acid 3, diffractaic acid 
4 and perlatolic acid 6 their values were 32%, 14% and 45%, respectively. Our results suggest that lichens have potential as a suite of gastroprotective molecules. 
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INTRODUCTION
Currently, gastroprotection is defined as the ability of certain endogenous 
factors and drugs to counteract gastric mucosal damage through mechanisms 
unrelated to inhibition of acid secretion. It is generally agreed that the 
gastroprotection depends on the balance between aggressive and defensive 
mechanisms and that the success of any treatment (gastric ulcers, upper 
gastrointestinal complications) does not only depend on the blockade of acid 
secretion but also on the enhancement of mucosal protective mechanisms.1,2           
Lichens are symbiotic organisms between fungi and algae or cyanobacteria. 
They occur in a wide range of habitats: from polar to tropical regions, from aquatic 
to xeric conditions, on the highest mountains, and in extreme environmental 
conditions (extreme temperatures, high salinity).3 Secondary metabolites from 
lichens are known as lichen substances and are mainly derived from the acetyl-
polymalonate pathway such as aliphatic acids, depsides, depsones, depsidones, 
dibenzofurans, usnic acids, xanthones, naphthoquinones, anthraquinones and 
anthrones. Many lichen substances have a unique range of biological effects 
such as antioxidant, anti-allergic, anti-inflammatory, analgesic, antipyretic, 
antimicrobial, insecticidal, antiherbivore, anticancer, antiviral, cytotoxic, UV-
protecting agent, and immunomodulatory.3-5 However, the effects of psoromic 
acid, diffractaic acid, atranorin, lobaric acid, perlatolic acid and variolaric acid 
on the prevention of gastric lesions on the model of HCl/ethanol in mice has 
not been investigated to date. Only, diffractaic acid and usnic acid have shown 
gastroprotective activity in other models.6-7                  
In this study, we report the gastroprotective activity of six known lichen 
substances from different lichen species collected in diverse localities of Chile 
Continental and Antarctic, in the HCl/EtOH-induced gastric lesion model in 
mice. 
EXPERIMENTAL
Lichens
The tested metabolites arose from different lichen species collected in 
diverse localities of Chile continental and Antarctic. The orcinol depsidone 
lobaric acid 1 was isolated from Stereocaulon alpinum Laur. collected in Robert 
Island and in Ardley Cove ( King George Island), Antarctic.8 Atranorin 2, an 
b-orcinol depside, was obtained from Buellia cladocarpisa Lamb. collected in 
Copper Mine Cove, Robert Island, Shetland del Sur, Antarctic.8 The depsidone 
variolaric acid 3 isolated from Ochrolechia deceptionis Hue. collected in King 
George Island, near Marsh Base, Antarctic.9 From Protousnea magellanica 
(Mont) Krog collected in Laguna Icalma, IX Region, Chile was isolated 
diffractaic acid 4.10 The lichen depsidone psoromic acid 5 was obtained from 
Ingaderia pulcherrima Darb. collected at Pan de Azúcar National Park, III 
Region, Chile.11 Perlatolic acid 6 obtained from Stereocaulon sp. collected in 
Parque Nacional Puyehue, X Region, Chile.      
Extraction, isolation and identification of lichen compounds
This lichen compounds were obtained as has already been reported.8-11 
The compounds 1-6 were dissolved in 0.8 mL of CD3COCD3 containing 
tetramethylsilane (TMS) as internal standard. 1H-NMR spectra were measured 
at 400.13 MHz on a Bruker instrument and chemical shift (d) reported in ppm.
The 1H-NMR spectrum of 1 indicated the presence of three aromatic 
signals at δ 7.03 (1H, d, J = 2.2), 7.02 (1H, d, J = 2.2) and 6.78 (1H, s); a 
methoxy group at δ 3.98 (3H, s); three methylene protons at δ 3.25 (2H, m, 
-CO), 2.86 (2H, m, -phenyl) and 1.39-1.63 (10H, -aliphatic); and two methyl 
groups signals at δ 0.92 (3H, t, J = 7.3), 0.91 (3H, t, J = 7.3). These signals are 
characteristic of lobaric acid.12  
The compound 2 was established as follows: The 1H-NMR spectrum 
showed signals for three H-O phenolic at δ 12.5 (1H, s), 12.3 (1H, s), 11.9 
(1H, s); for an aldehyde proton at δ 10.4 (1H, s); for two aromatic protons at δ 
6.77 (1H, s) and 6.51 (1H, s); along with a methyl ester at δ 4.02 (3H, s) and 
three methyl groups at δ 2.70 (3H, s), 2.55 (3H, s) and 2.09 (3H, s). These data 
showed that this compound is atranorin.12  
The 1H-NMR spectrum of 3 showed three aromatic protons at δ 6.98 (1H, 
s), 6.88 (1H, d, J = 1.9) and 6.73 (1H, d, J = 1.9); a methylene singlet at high 
field (δ 5.28) and a methyl group at δ 2.41 (3H, s). These data are consistent 
with variolaric acid.13      
Diffractaic acid 4 showed two aromatic signals at δ 6.76 (1H, s) and 6.68 
(1H, s) in the 1H-NMR spectrum, along with two methoxy groups at δ 3.89 (3H, 
s), 3.83 (3H, s) and four singlet methyls at δ 2.62 (3H, s), 2.44 (3H, s), 2.14 
(3H, s) and 2.13 (3H, s).6, 10      
The 1H-NMR spectrum of psoromic acid 5 showed signals for an aldehyde 
group at δ 10.58 (1H, s); for two aromatic protons at δ 7.22 (1H, s) and 6.79 
(1H, s); for a methoxy group at δ 3.93 (3H, s) and signals at δ 2.52 (3H, s) and 
2.26 (3H, s) due to two methyls.14   
Perlatolic acid 6 in the 1H-NMR spectrum showed four aromatic protons at 
δ 6.79 (1H, d, J = 2.4), 6.76 (1H, d, J = 2.4), 6.47 (1H, d, J = 2.4) and 6.41 (1H, 
d, J = 2.4); a methoxy group at δ 3.86 s; and two penthyl groups at almost the 
same resonance (δ 3.03, 2.97, 1.67 and 1.35 for methylene protons and 0.89, 
0.86 for methyl groups).15     
Animals 
Animals were purchased from the Instituto de Salud Pública de Chile, 
Santiago. Swiss albino mice weighing 30 ± 3 g were fasted for 24h prior to the 
experiment. The animals were fed on certified Champion diet with free access 
to water under standard conditions of 12 h dark-light period, 50% relative 
humidity and 22 °C room temperature. The protocols were approved by the 
Animal Use and Care Committee of the Universidad de Chile that follows the 
recommendations of the Canadian Council on Animal Care and with the ethical 
guidelines for investigations in conscious animal.16     
HCl/Ethanol-induced gastric lesions and treatments
The gastroprotective activity of compounds 1-6 was assessed as described 
previously.17,18 Mice were allotted into groups of eight animals each. Fifty min 
after oral administration of lichen substances 1-6 (30 mg/kg), lansoprazole (30 
mg/kg, Sigma-Aldrich USA) or 1% Tween 80 (negative control or vehicle, 
Merck, Germany), were orally treated with 0.2 ml of a solution containing 
0.3M HCl/ 80% ethanol for gastric lesion induction. Animals were sacrificed 1 
h after the administration of HCl/ ethanol, and the stomachs were excised and 
inflated by injection of saline (2 ml). The ulcerated stomachs were fixed in 5% 
formalin for 30 min and opened along the greater curvature. Gastric damage 
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visible to the naked eye was observed in the gastric mucosa as elongated black-
red lines, parallel to the long axis of the stomach similar to the HCl/ethanol-
induced lesions in rats. The length (mm) of each lesion was measured, and the 
lesion index was expressed as the sum of the length of all lesions. 
Statistical analysis
Results were expressed as the mean ± S.D. In all experiments, statistical 
differences between several treatments and their respective control were 
determined by one-way analysis of variance (ANOVA) followed by the 
Dunnett’s multiple comparison tests. The level of significance was set at P 
< 0.01. All statistical analyses were performed using the software GraphPad 
Prism 4 for Windows. 
RESULTS AND DISCUSSION
The chemical structures of the compounds 1-6 are shown in Figure 1.
Fig. 1 Chemical structure of six compounds isolated from lichens. 
In the present study, the gastroprotective effect of lichen substances 1-6 
was evaluated in a model of gastric damage elicited by application of an 
ethanol/HCl solution in mice. Compounds 1-6 clearly decreased the gastric 
lesions at 30 mg/kg (Table 1). The inhibition displayed by lobaric acid (1, 
76%), atranorin (2, 63%) and psoromic acid (5, 65%) were similar to that 
observed with lansoprazole (69%), while for variolaric acid 3, diffractaic acid 
4 and perlatolic acid 6 their values were 32%, 14% and 45% respectively. 
Table 1 Gastroprotective effect of lansoprazole and the lichen substances 
1-6 on HCl/EtOH-induced gastric lesions in mice.
Compounds Dose (mg/kg) N
Lesion 
index (mm)
% 
Inhibition p
1 30 8 8.42 ± 2.6 76 < 0.01
2 30 8 13.57 ± 3.3 63 < 0.01
3 30 8 24.71 ± 3.5 32 < 0.01
4 30 8 31.29 ± 3.5 14 < 0.05
5 30 8  12.86 ± 1.8 65 < 0.01
6 30 8 19.86 ± 4.0 45 < 0.01
Lansoprazole 30 7 11.14 ± 3.8 69 < 0.01
Vehicle - 7 36.14 ± 4.3 - < 0.01
Healthy group - 6 - - -
Results are expressed as mean ± sd. P<0.05 or P<0.01 significantly 
different compared with the control (ANOVA followed by Dunnett’s test). N 
= animal number. 
Some gastroprotective metabolites from lichens are active at different 
oral doses in rats. Bayir et al. (2006)6 studied the antiulcerogenic activity 
of 4 on indomethacin-induced gastric lesions in rat as well as the activities 
of the antioxidant enzymes as superoxide dismutase, catalase, glutathione 
peroxidase, and the level of reduced glutathione and lipid peroxidation. In that 
study, diffractaic acid at 25, 50, 100 and 200 mg/kg reduced the ulcer index by 
43.5%, 52.9%, 91.4% and 96.7%, respectively. Therefore, Bayir et al. (2006) 
showed that 4 had significant gastroprotective activity and it was attributed to 
an enhancing on antioxidant defense systems.
Other study of the antiulcerogenic activity of usnic acid, one of the most 
common and abundant lichen substances, has been reported.7 In indomethacin-
induced gastric lesions in rat, usnic acid reduced the gastric lesions by 92.9%, 
80.2%, 96.4% and 88.3% at 25, 50, 100 and 200 mg/kg, respectively. They 
concluded that the gastroprotective activity of usnic acid was due to its 
reducing effect against oxidative damage and its inhibitory effect on neutrophil 
infiltration in stomach rat tissues. 
It is well known that ethanol/HCl evoke acute tissue damage, oxidative 
damage, hemorrhages, cellular exfoliation, infiltration by inflammatory 
cells and generation of ROS.19 Our results showed that compound 1, 2 and 
5 exhibited significant gastroprotective activity at 30 mg/kg. Lobaric acid 
1 showed the best gastroprotective effect while diffractaic acid 4 presented 
the lowest gastroprotective activity in our study. However, their effects of 4 
cannot be compared than other studies since both models have mechanisms 
different. Compound 4 at 25 mg/kg reduced the gastric lesion by 43.5% on 
indomethacin-induced gastric lesions in rat,6 while at 30 mg/kg reduced the 
lesions by 14% on the model of HCl/ethanol in mice. 
Some extracts from lichen species have showed to reduce the gastric lesions 
in other models. For instance, water-ethanol extract of Ramalina capitata 
showed gastroprotective activity at 200 mg/kg on the indomethacin-induced 
gastric lesion model in rats. The authors suggested that the gastroprotective 
activity displayed by the extracts could be attributed to the antioxidant activity.20 
Karakus et al. (2009)21 reported the gastroprotective effect of the methanol 
extract of Lobaria pulmonaria against indomethacin-induced gastric lesions. It 
was suggested that the gastroprotective effect could be due to reducing oxidative 
stress and neutrophil infiltration. Other study includes the antiulcerogenic and 
antioxidant effect at 50, 100 and 200 mg/kg of a water extract from Usnea 
longissima, which it was attributed to its antioxidant potential.22   On the other 
hand, some alkaloids, flavonoids, terpenoids or their derivatives have been 
shown to have gastroprotective properties. Some reviews have been published 
whose discussion is related the chemical nature and mechanism of action of 
natural products as gastroprotective agents.23-26 Gastroprotective compounds 
seem to work mainly stimulating the defensive factor in the gastric mucosa 
rather than inhibiting the aggressive factors such as pepsin or gastric acid. 
Further studies are needed to assess the action mechanisms of the lichen 
substances. However, additional work should be undertaken to isolate other 
compounds from lichens and to assess their gastroprotective effects. 
In conclusion, several pharmacological activities have been reported during 
the last 25 years for lichen substances but none related with gastroprotective 
activity using the model of HCl/ethanol-induced gastric lesions in mice. 
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